The Reply

Affiliations

¹ Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, Mass.
² Division of Cardiology, University of Texas Southwestern Medical Center, Dallas.

Comment

Muthiah Vaduganathan et al. Am J Med. 2018 Jun.

. 2018 Jun;131(6):e267-e268.

doi: 10.1016/j.amjmed.2017.12.043.

¹ Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, Mass.
² Division of Cardiology, University of Texas Southwestern Medical Center, Dallas.

No abstract available

Comment on

Patent Foramen Ovale Closure for Secondary Prevention of Cryptogenic Stroke: Updated Meta-Analysis of Randomized Clinical Trials.
Vaduganathan M, Qamar A, Gupta A, Bajaj N, Golwala HB, Pandey A, Bhatt DL. Vaduganathan M, et al. Am J Med. 2018 May;131(5):575-577. doi: 10.1016/j.amjmed.2017.11.027. Epub 2017 Dec 8. Am J Med. 2018. PMID: 29229471 Free PMC article.
Patent Foramen Ovale Closure Versus Medical Therapy After Cryptogenic Stroke.
Tie HT, Shi R. Tie HT, et al. Am J Med. 2018 Jun;131(6):e265-e266. doi: 10.1016/j.amjmed.2017.12.035. Am J Med. 2018. PMID: 29784197 No abstract available.